ScreenerHero

PEPG PepGen Inc.

NAS · US · Healthcare · Biotechnology · pepgen.com
2.400USD+3.90%Mkt Cap: 166.22M $P/E: —

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap166.22M USD
Enterprise Value58.84M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-89.66M USD
Revenue/Share—
Last Price2.400 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees57
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.23
PEG—
EV/EBITDA-0.79
EV/Revenue—
P/S—
P/B1.34
EPS (TTM)-0.99
EPS (Forward)-1.04
52W Range
1.31017% of range7.800
52W High7.800 USD
52W Low1.310 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-60.81%
ROA-51.55%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-81.64M USD
CapEx (TTM)264.00K USD
FCF Margin—
FCF Yield-26.02%
Net Debt-101.14M USD
Net Debt/EBITDA1.35
Balance Sheet
Debt/Equity0.12
Current Ratio13.36
Quick Ratio13.02
Book Value/Sh1.73 USD
Cash/Share1.69 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)10.19 USD
Upside (mean)+324.5%
Target Range2.500 USD – 20.00 USD
2.500+324.5% to mean20.00
# Analysts8
Ownership
Shares Out.69.26M
Float36.14M
Insiders0.23%
Institutions82.86%
Short Interest
Short Ratio5.4d
Short % Float7.89%
Short % Out.5.59%
Shares Short3.87M
Short (prev mo.)4.39M
Technical
SMA 502.730 (-12.1%)
SMA 2003.368 (-28.7%)
Beta2.01
S&P 52W Chg16.45%
Avg Vol (30d)805.74K
Avg Vol (10d)978.22K
Technical Indicators
RSI (14)41.0
MACD-0.1292
MACD Signal-0.0676
MACD Hist.-0.0616
BB Upper3.356 USD
BB Middle2.703 USD
BB Lower2.050 USD
BB Width48.35%
ATR (14)0.1873 USD
Vol Ratio (20d)0.73x